PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Health Decisions

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Adaptive Monitoring Improves Clinical Research Efficiency – DIA Invites Health Decisions to Discuss - Health Decisions CEO Dr. Michael Rosenberg will explore the implications of advanced e-monitoring models during two sessions at the DIA 4th Annual Clinical Forum
Adaptive Monitoring Improves Clinical Research Efficiency – DIA Invites Health Decisions to Discuss

 

NewswireToday - /newswire/ - Durham, NC, United States, 2010/10/06 - Health Decisions CEO Dr. Michael Rosenberg will explore the implications of advanced e-monitoring models during two sessions at the DIA 4th Annual Clinical Forum.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Health Decisions, a full-service clinical research organization (CRO) specializing in high-efficiency adaptive methods, will be represented by CEO Dr. Michael Rosenberg at the DIA 4th Annual Clinical Forum October 11 -13 in Lisbon, Portugal. Dr. Rosenberg will address the Forum with a presentation titled “Adaptive Monitoring: Faster, Better e-Monitoring.” It will highlight the advantages and requirements of adopting innovative monitoring methods and technologies.

“An adaptive monitoring system builds on the same basic principles as adaptive design. But instead of interim reviews of patient data, adaptive monitoring deals with operational metrics on an iterative, day-to-day scale,” said Dr. Rosenberg. “With the ability to access constant flows of meaningful metrics in near-real time, study teams can respond more quickly—often preemptively—to emerging problems. As a result, drug and device developers benefit from better quality data, more efficient use of resources, and substantially shorter program cycles.”

“Adaptive Monitoring: Faster, Better e-Monitoring” will be presented during two Forum sessions at the Lisboa Congress Centre. The first session, Adaptive Design for Clinical Trials: Issues and Solutions, will take place Tuesday, October 12 from 9:00 to 10:30 AM WEST.

Dr. Rosenberg will repeat the presentation on Wednesday, October 13 from 9:00 to 10:30 AM WEST as part of the Monitoring Strategies for the Future session, chaired by Nermeen Y. Varawalla, CEO of ECCRO and featuring additional presentations from Kendle and Reliance Clinical Research Services. The DIA website provides additional information about the sessions, including a full program and registration information.

About Health Decisions
Health Decisions (healthdec.com) is a global clinical research organization (CRO) committed to helping drug and device companies achieve greater success. Our sponsors rely on us to help them prove the value of their pipelines both faster and with the smartest possible allocation of funds. Through Agile Clinical Development—a strategic combination of adaptive design and adaptive operations—Health Decisions optimizes every facet of clinical research from design protocol to the most detailed day-to-day management, so sponsors can make the most of competitive market opportunities.

Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors achieve success in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at the link accompanying this press release.

About DIA
DIA (diahome.org) is a neutral, global, professional, member-driven association of nearly 18,000 biotechnology, pharmaceutical, clinical or medical, academic and regulatory professionals, students and patient representatives. Through its international meetings, training courses, online learning and myriad networking opportunities, the DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit the website or call DIA in Europe +41 61 225 51 51

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Health Decisions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Adaptive Monitoring Improves Clinical Research Efficiency – DIA Invites Health Decisions to Discuss

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Katie Hendrick - HealthDec.com 
919-967-1111 x116 khendrick[.]healthdec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Health Decisions securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Health Decisions / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)